PS-001 (Purespring Therapeutics)

N/A

Report date: 2024/06/26 12:00:43

Base Information

Drug NamePS-001 (Purespring Therapeutics)
Drug Alias NamePS-001 (Purespring Therapeutics)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionPodocin gene transference
TargetsPodocin
Therapy Area/IndicationsNephrotic Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPurespring Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPurespring Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsNephrotic Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A